The medical device industry’s efforts to repeal an impending 2.3% tax on sales continue to run in high gear as Ohio’s med-tech industry discusses impacts with local legislators and a Congressional GOP group takes the rhetoric and runs with it.
The Sunnyvale, Calif.-based radiosurgery device maker reported losses of $14.9 million, or 21¢ per share, on sales of $101.8 million during the 3 months ended March 31.
Cooper Cos. (NYSE:COO) today announced that the U.S. Food and Drug Administration has granted a Special 510(k) clearance for CooperVision’s Avaira Toric two-week silicone hydrogel contact lenses for astigmatism.
CooperVision will re-launch Avaira Toric with shipments available for select distribution beginning in early May 2012.
Steris Corp. (NYSE:STE) landed special 510(k) clearance to modify its System 1E sterilizers, the replacement systems for the troubled System 1 devices that were the center of a 2-year row with the FDA.
The Mentor, Ohio-based device maker won the FDA’s approval to update existing SS1E devices in the field with modified software, which will also be applied to all new shipments, effective immediately.
MASSDEVICE ON CALL — A growing number of students claim to know a peer who is using prostitution to pay for med school, according to a new study published in the British Medical Journal.
1 in 10 students surveyed claimed to know someone in the sex trade as a last resort for paying tuition, up from 6% of those surveyed in 2006 and 4% in 2002.
Thoratec (NSDQ:THOR) shares are up more than 11% today after the heart pump maker put mid-double-digit profit growth numbers on the board for the 4th quarter and full-year 2011.
The Pleasanton, Calif.-based cardiac assist device maker logged profits of $15.3 million, or 25 cents per diluted share, on sales of $109.4 million for the 3 months ended Dec. 31, 2011. That’s a 46.4% bottom-line gain and a top-line boost of 12.1%, compared with profits of $10.5 million, or 17 cents diluted EPS, on sales of $97.6 million during Q4 2010.
Financial projections from AngioDynamics (NSDQ:ANGO) about its $372 million deal to acquire Navilyst Medical show that it expects to reap some significant rewards from the merger over the short and long terms.
Group purchasing organizations Novation and Premier inked 8 new supply contracts for OR integration and automation systems, dialysis equipment and patient monitoring equipment.
Steris Corp. (NYSE:STE) customers have an extra 6 months from the FDA to transition from the company’s recalled System 1 sterilization device.
The med-tech maker will support current System 1 devices until August 2, 2012 but only in companies that provide a certificate of transition identifying the proposed installation date of replacement technology, according to an SEC filing.
Sterilization and decontamination technology firm Steris Corp. (NYSE:STE) opened a new European headquarters in Bordeaux, France.
In the 85,000 square-foot facility, Steris combined marketing, manufacturing, sales, costumer service and research & development.
Steris Corp. (NYSE:STE) and Toshiba Medical Systems Corp. struck a deal to collaborate on creating hybrid operating room suites.
The hybrid suites allow surgical and diagnostic teams to perform open surgeries and carry out a wide range of image-guided cardiovascular, vascular and neurosurgical procedures without moving a patient from room to room.